The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis

Lipids in Health and Disease

Volumn 6, Issue , 2007, Pages

  Al Daghri, Nasser M ^a   Al Attas, Omar S ^a   Al Rubeaan, Khalid ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; LIPID;

ADULT; AGED; ARAB; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREDICTION; QUESTIONNAIRE; RISK FACTOR; ATHEROSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; LIPID METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; SAUDI ARABIA;

ADULT; ATHEROSCLEROSIS; CHOLESTEROL; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; LIPID METABOLISM; LIPIDS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SAUDI ARABIA;

EID: 34247585187     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-6-9     Document Type: Article

References (18)

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
2. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. R Jiang MB Schulze T Li N Rifai MJ Stampfer EB Rimm FB Hu, Diabetes Care 2004 27 1992 1997 10.2337/diacare.27.8. 1991
3. Non-HDL cholesterol as a measure of atherosclerotic risk. CJ Packard Y Saito, J Atheroscler Thromb 2003 11 1 6 14
4. Coronary artery disease in Saudi Arabia. MM Al-Nozha MR Arafah YY Al-Mazrou MA Al-Maatouq NB Khan MZ Khalil AH Al-Khadra K Al-Marzouki MA Abdullah SS Al-Harthi MS Al-Shahid MS Nouh A Al-Mobeireek, Saudi Med J 2004 25 1165 1171 15448760
5. Case Definitions for acute coronary heart disease in epidemiology and case-research studies: A statement from the AHA council on epidemiology and prevention; World Health Federation council on epidemiology and prevention; the European Society of cardiology working group on epidemiology and prevention; Centers for disease control and prevention; and the National Heart, Lung and Blood Institute. RV Luepker FS Apple RH Christenson RS Crow SP Fortmann D Goff RJ Goldberg MM Hand AS Jaffe DG Julian D Levy T Manolio S Mendis G Mensah A Pajak RJ Prineas KS Reddy VL Roger WD Rosamond E Shahar AR Sharrett P Sorlie H Tunstall-Pedoe AHA Council on Epidemiology and Prevention, AHA Statistics Committee, World Heart Federation Council on Epidemiology and Prevention, European Society of Cardiology Working Group on epidemiology and Prevention, Centers for Disease Control and Prevention, National Heart, Lung and Blood Institute, Circulation 2003 108 2543 2549 10.1161/01.CIR.0000100560.46946.EA 14610011
6. Non-high density lipoprotein cholesterol level as a potential risk predictor and therapy target. SM Grundy, Arch Int Med 2001 161 1379 1380 10.1001/archinte.161.11.1379
7. Non-HDL cholesterol level as a reliable early predictor for vascular inflammation in type 2 diabetes mellitus. C Wang T Chang, The Journal of Endocrinology and metabolism 2004 89 9 4762 4767 10.1210/jc.2004-0820
8. Joint distribution of Non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. J Liu C Sempos RP Donahue J Dorn M Trevisan SM Grundy, Diabetes Care 2005 28 8 1916 1921 10.2337/diacare.28.8.1916 16043732
9. The relationship between non-HDL cholesterol and other lipid parameters in Japanese subjects. K Sugimoto K Isobe Y Kawakami N Yamada, J Atheroscler Thromb 2004 12 2 107 110
10. Non-high density lipoprotein cholesterol as a predictor of cardiovascular risk mortality. Y Cui RS Blumenthal JA Flaws MK Whiteman P Langenberg PS Bachorik TL Bush, Arch Intern Med 2001 161 1413 1419 10.1001/archinte.161.11. 1413 11386890
11. Non-HDL cholesterol: into the spotlight. SH Hsia, Diabetes Care 2003 26 240 242 10.2337/diacare.26.1.240 12502688
12. Low density-lipoprotein, non-high density lipoprotein, and apo-lipoprotein B as targets of lipid-lowering therapy. SM Grundy, Circulation 2002 106 2526 2529 10.1161/01.CIR.0000038419.53000.D6 12427645
13. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological study. AR Al-Nuaim K Al-Rubeaan Y Al-Mazrou O Al-Attas NM Al-Daghri, Int J Cardiol 1996 54 1 41 49 10.1016/0167-5273(96)02555-7 8792184
14. Hyperlipidemia, alcohol abuse and acute pancreatitis. AP Dickson J O'Neill CW Imrie, Br J Surg 1984 71 9 685 688 10.1002/bjs.1800710913 6206908
15. Alcohol and atherosclerosis. PL daLuz SR Coimbra, An Acad Bras Cienc 2001 73 1 51 5 11246269
16. Hyperlipidemia: Diagnostic and therapeutic perspectives. CM Ballantyne Grundy SM A Oberman RA Kreisberg RJ Havel PH Frost SM Haffner, The Journal of Clinical Endocrinology and Metabolism 2000 85 6 2089 2112 10.1210/jc.85.6.2089
17. Population based frequency of dyslipidemia syndromes in coronary-prone families in Utah. RR Williams PN Hopkins SC Hunt LL Wu TD Berry BM Stults H Kuida, Arch Intern Med 1990 150 582 588 10.1001/archinte.150.3.582 2310276
18. Risk factors in middle age that predict early and late onset of coronary heart disease. RJ Benfante DM Reed CJ MacLean K Yano, J Clin epidemiol 1989 42 95 104 10.1016/0895-4356(89)90082-6 2918328